Literature DB >> 15462285

Expression of herpes simplex virus 1 glycoprotein D in prokaryotic and eukaryotic cells.

T Mosko1, J Kosovský, I Rezuchová, V Durmanová, M Kúdelová, J Rajcáni.   

Abstract

Recombinant plasmids encoding either the full-length glycoprotein D (FLgD) or truncated gDs were constructed. The recombinant plasmids were expressed in Escherichia coli and BHK-21 cells. The strongest expression was obtained with the recombinant plasmid encoding a truncated gD which corresponded to the gD ectodomain. The cells transformed with this plasmid showed good exponential growth ensuring satisfactory yields of the expressed polypeptide in the form of the fusion protein. The fusion protein was biotinylated and efficiently purified. The shortest truncated gD, which contained the main continuous antigenic locus VII binding neutralization antibody and additional continuous antibody binding epitopes, still reacted with specific antibody as proven by immunoblot analysis. In addition, a shuttle vector for expression of FLgD in mammalian cells was constructed. This vector-transfected BHK-21 cells expressed gD for 40 days during 9 consecutive passages. The expression of gD began on day 2 and culminated at day 9 post transfection (p.t.).

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15462285

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  2 in total

1.  The antiviral activity of kaempferol against pseudorabies virus in mice.

Authors:  Lixia Li; Rui Wang; Huaiyue Hu; Xu Chen; Zhongqiong Yin; Xiaoxia Liang; Changliang He; Lizi Yin; Gang Ye; Yuanfeng Zou; Guizhou Yue; Huaqiao Tang; Renyong Jia; Xu Song
Journal:  BMC Vet Res       Date:  2021-07-18       Impact factor: 2.741

2.  Immune response and cytokine production following immunization with experimental herpes simplex virus 1 (HSV-1) vaccines.

Authors:  V Durmanová; M Sapák; J Kosovský; I Rezuchová; M Kúdelová; M Buc; J Rajcáni
Journal:  Folia Microbiol (Praha)       Date:  2008-05-15       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.